96 related articles for article (PubMed ID: 16097156)
21. Urethral injection for stress urinary incontinence: long-term results with dextranomer/hyaluronic acid copolymer.
Stenberg AM; Larsson G; Johnson P
Int Urogynecol J Pelvic Floor Dysfunct; 2003 Nov; 14(5):335-8; discussion 338. PubMed ID: 14618311
[TBL] [Abstract][Full Text] [Related]
22. [Efficacy of periurethral injections of polyacrylamide hydrogel (Bulkamid(®)) and quality of life of patients with urinary incontinence due to sphincter deficiency (IUE-IS)].
Beraru A; Droupy S; Wagner L; Soustelle L; Muyschondt C; Ben Naoum K; Grés P; Boukaram M; Costa P
Prog Urol; 2014 Jun; 24(8):501-10. PubMed ID: 24875569
[TBL] [Abstract][Full Text] [Related]
23. Oral and local anesthesia in the nonsurgical radiofrequency-energy treatment of stress urinary incontinence.
Lenihan JP; Palacios P; Sotomayor M
J Minim Invasive Gynecol; 2005; 12(5):415-9. PubMed ID: 16213427
[TBL] [Abstract][Full Text] [Related]
24. DiHA Dextran Copolymer, a new biocompatible material for endoscopic treatment of stress incontinent women. Short term results.
Stenberg A; Larsson G; Johnson P; Heimer G; Ulmsten U
Acta Obstet Gynecol Scand; 1999 May; 78(5):436-42. PubMed ID: 10326891
[TBL] [Abstract][Full Text] [Related]
25. Retrospective analysis after endoscopic urethral injections of glutaraldehyde-cross-linked-collagen or dextranomer/hyaluronic acid copolymer in bitches with urinary incontinence.
Lüttmann K; Merle R; Nickel R
J Small Anim Pract; 2019 Feb; 60(2):96-101. PubMed ID: 30387491
[TBL] [Abstract][Full Text] [Related]
26. Treating urethral sphincter damage caused by long-term urethral catheterisation with a Zuidex periurethral injection and suprapubic catheter.
Papanikolaou NS; Duckett J
J Obstet Gynaecol; 2008 Apr; 28(3):361-2. PubMed ID: 18569498
[No Abstract] [Full Text] [Related]
27. Minimally invasive treatment of vesicoureteral reflux with endoscopic injection of dextranomer/hyaluronic acid copolymer: the Children's Hospitals of Atlanta experience.
Kirsch AJ; Perez-Brayfield MR; Scherz HC
J Urol; 2003 Jul; 170(1):211-5. PubMed ID: 12796692
[TBL] [Abstract][Full Text] [Related]
28. Endoscopic treatment with dextranomer/hyaluronic acid for persistent incontinence after continent urinary reconstruction.
Riachy E; Defoor WR; Reddy PP; Alam S; Noh PH; Sheldon C; Minevich EA
J Endourol; 2015 Feb; 29(2):137-40. PubMed ID: 25265053
[TBL] [Abstract][Full Text] [Related]
29. Stress incontinence injection therapy: what is best for our patients?
Chapple CR; Wein AJ; Brubaker L; Dmochowski R; Pons ME; Haab F; Hill S
Eur Urol; 2005 Oct; 48(4):552-65. PubMed ID: 16118034
[TBL] [Abstract][Full Text] [Related]
30. [Use of bulking agents in urinary incontinece].
Angioli R; Muzii L; Zullo MA; Battista C; Ruggiero A; Montera R; Guzzo F; Montone E; Musella A; Di Donato V; Benedetti Panici P
Minerva Ginecol; 2008 Dec; 60(6):543-50. PubMed ID: 18981980
[TBL] [Abstract][Full Text] [Related]
31. Open-label study evaluating outpatient urethral sphincter injections of onabotulinumtoxinA to treat women with urinary retention due to a primary disorder of sphincter relaxation (Fowler's syndrome).
Panicker JN; Seth JH; Khan S; Gonzales G; Haslam C; Kessler TM; Fowler CJ
BJU Int; 2016 May; 117(5):809-13. PubMed ID: 26435296
[TBL] [Abstract][Full Text] [Related]
32. Treatment of stress urinary incontinence using a copolymer system: impact on quality of life.
van Kerrebroeck P; ter Meulen F; Larsson G; Farrelly E; Edwall L; Fianu-Jonasson A
BJU Int; 2004 Nov; 94(7):1040-3. PubMed ID: 15541124
[TBL] [Abstract][Full Text] [Related]
33. [Management of male urinary incontinence after radical prostatectomy (CTMH AFU 2006 - 4/5): place of intraurethral macroplastique injection, artificial urinary sphincter and cell therapy].
Fourmarier M; de la Taille A; Azzouzi AR; Ballereau C; Desgranchamps F; Devonec M; Haillot O; Lukacs B; Castel E; Saussine C
Prog Urol; 2008 Feb; 18(2):85-8. PubMed ID: 18396234
[TBL] [Abstract][Full Text] [Related]
34. Single-institution experience in 110 patients with botulinum toxin A injection into bladder or urethra.
Smith CP; Nishiguchi J; O'Leary M; Yoshimura N; Chancellor MB
Urology; 2005 Jan; 65(1):37-41. PubMed ID: 15667859
[TBL] [Abstract][Full Text] [Related]
35. Transurethral polydimethylsiloxane injection: a valid minimally invasive option for the treatment of postradical hysterectomy urinary incontinence.
Zullo MA; Plotti F; Calcagno M; Angioli R; Panici PB
J Minim Invasive Gynecol; 2008; 15(3):373-6. PubMed ID: 18439516
[TBL] [Abstract][Full Text] [Related]
36. Endoscopic injection of bulking agents in children with incontinence: dextranomer/hyaluronic acid copolymer versus polytetrafluoroethylene.
Dyer L; Franco I; Firlit CF; Reda EF; Levitt SB; Palmer LS
J Urol; 2007 Oct; 178(4 Pt 2):1628-31. PubMed ID: 17707036
[TBL] [Abstract][Full Text] [Related]
37. Complications of ethylene vinyl alcohol copolymer as an intraurethral bulking agent in men with stress urinary incontinence.
Hurtado EA; McCrery RJ; Appell RA
Urology; 2008 Apr; 71(4):662-5. PubMed ID: 18279931
[TBL] [Abstract][Full Text] [Related]
38. Bladder ultrasound in the evaluation of the efficacy of dextranomer/hyaluronic acid injection for treatment of vesicoureteral reflux.
Ozcan C; Ergün R; Ozbek SS; Avanoğlu A; Ulman I
J Clin Ultrasound; 2007 Sep; 35(7):357-62. PubMed ID: 17523192
[TBL] [Abstract][Full Text] [Related]
39. Endoscopic treatment of moderate and high grade vesicoureteral reflux in infants using dextranomer/hyaluronic acid.
Puri P; Mohanan N; Menezes M; Colhoun E
J Urol; 2007 Oct; 178(4 Pt 2):1714-6; discussion 1717. PubMed ID: 17707016
[TBL] [Abstract][Full Text] [Related]
40. [Prospective study of the therapeutic usefulness and safety of a new disposable intraurethral occlusive device (Uriabsorber) for female stress urinary incontinence].
Vírseda Chamorro M; Salinas Casado J; Esteban Fuertes M; Mañas Pelillo A; Teba del Pino F
Arch Esp Urol; 2004; 57(6):625-32. PubMed ID: 15382438
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
